Type 2 Diabetes Mellitus Therapeutics Market 2022 Type 2 Diabetes Mellitus Therapeutics Market 2022

Type 2 Diabetes Mellitus Therapeutics
Market is expected to increase in value at a
CAGR of $2.7 billion 2022: Radiant Insights,
Inc.
“Over the 2015-2022 forecast period, the South-East
Asia T2DM therapeutics market is expected to
increase in value at a CAGR of 7.1%, from $1.7
billion to over $2.7 billion.”
Summary
Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia- high
blood glucose levels - that results from defects in insulin secretion, insulin action, or a combination
of these. This chronic hyperglycemia is associated with long-term damage, dysfunction and failure
of multiple organs, including the eyes, kidneys, nerves, heart and blood vessels. The vast majority
of diabetes mellitus patients can be classified as having either Type 1 Diabetes Mellitus (T1DM) or
Type 2 Diabetes Mellitus (T2DM). Approximately 90-95% of all diabetics have T2DM.
T2DM treatment has been revolutionized in the past decade, especially with the increased use of
new therapies. The marketed products landscape comprises a wide range of treatment options,
including biguanide (metformin), sulfonylureas, thiazolidinediones, GLP-1 receptor agonists,
Click For Report Details @ http://www.radiantinsights.com/research/type-2-diabetes-
mellitus-therapeutics-in-south-east-asia-markets-to-2022
Follow Us: